Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

High-Throughput Mechanistic Screening of Epigenetic Compounds for the Potential Treatment of Meningiomas
Philip D. Tatman, Tadeusz Wroblewski, Anthony Fringuello, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 14, pp. 3150-3150
Open Access | Times Cited: 11

Showing 11 citing articles:

Targeting histone deacetylase 6 (HDAC6) to enhance radiation therapy in meningiomas in a 2D and 3D in vitro study
Juri Na, Shahana Shaji, C. Oliver Hanemann
EBioMedicine (2024) Vol. 105, pp. 105211-105211
Open Access | Times Cited: 6
Noncoding RNA landscape and their emerging roles as biomarkers and therapeutic targets in meningioma
R. K. Joshi, Anuja Sharma, Ritu Kulshreshtha
Deleted Journal (2024) Vol. 32, Iss. 1, pp. 200782-200782
Open Access | Times Cited: 2
A novel patient-derived meningioma spheroid model as a tool to study and treat epithelial-to-mesenchymal transition (EMT) in meningiomas
Laurien L. van de Weijer, Emanuela Ercolano, Ting Zhang, et al.
Acta Neuropathologica Communications (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 6
Histone deacetylase inhibitors enhance oncolytic herpes simplex virus therapy for malignant meningioma
Yoichiro Kawamura, Lingyang Hua, Alessandra Gurtner, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 155, pp. 113843-113843
Open Access | Times Cited: 8
ITF2357 induces cell cycle arrest and apoptosis of meningioma cells via the PI3K-Akt pathway
Lingying Zhang, Chengyu Li, Marhaba·Aziz, et al.
Medical Oncology (2022) Vol. 40, Iss. 1
Closed Access | Times Cited: 6
Personalized Medicine for Meningiomas: Drug Screening on Tumor Organoids Exposes Therapeutic Vulnerabilities to HDAC1/2i Panobinostat
Gerhard Jungwirth, Junguo Cao, Catharina Lotsch, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
A Review of Recurrent Meningiomas with Prolonged Response to Cabozantinib, an Oral Multitarget Tyrosine Kinase Inhibitor
Teboho Moerane, Vuyiswa Kama
(2023)
Open Access | Times Cited: 1
A Review of Recurrent Meningiomas with Prolonged Response to Cabozantinib, an Oral Multitarget Tyrosine Kinase Inhibitor
Teboho Alfred Moerane
(2023)
Open Access
A Review of Recurrent Meningiomas with Prolonged Response to Cabozantinib, an Oral Multitarget Tyrosine Kinase Inhibitor
Teboho Alfred Moerane
(2023)
Open Access
High-Throughput Screening of Epigenetic Inhibitors in Meningiomas Identifies HDAC, G9a, and Jumonji-Domain Inhibition as Potential Therapies
Philip D. Tatman, Tadeusz Wroblewski, Anthony Fringuello, et al.
Journal of Neurological Surgery Part B Skull Base (2022) Vol. 84, Iss. 05, pp. 452-462
Open Access
ITF2357 Induces Cell Cycle Arrest and Apoptosis in Meningioma Cells
Lingying Zhang, Chengyu Li, Maierhaba Aizezi, et al.
Research Square (Research Square) (2022)
Open Access
Page 1

Scroll to top